MGRX logo

MANGOCEUTICALS INC

MGRXNASDAQ
πŸ† #4211 by market capUS Equity
$0.55β–Ό $0.04 (βˆ’8.16%)
πŸŒ… Pre-market$0.53β–Ό 2.91%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 8.2%
7dβ–² 25.0%
14dβ–² 2.8%
30dβ–² 54.0%
1yβ–Ό 67.5%
🏦Market Cap
$9M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-26.0%
Declining
πŸ“ŠGross Margin
52.4%
Healthy
πŸ’΅FCF Margin
-1178.7%
Thin
βš–οΈP/S Ratio
22.3x
Expensive
Otter Score
44
Weak

Trading Snapshot

Day Range
$0.54 – $0.55
52-Week Range
$0.16 – $2.75
Volume
$5.20B
Avg Volume
$4.80B
Shares Outstanding
17.0M
Next Earnings
Oct 2, 2026

Fundamentals Snapshot

Annual Revenue
$456,021
Last Q Revenue
$67,864
P/E Ratio
-0.3
P/S Ratio
22.3x
EPS (TTM)
$-1.91
Dividend Yield
0.00%

Why Investors Own MGRX

  • βœ“High-growth profile β€” revenue up +47.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 73% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$456,021β–² +53.5% YoY
Gross Margin (TTM)
72.5%β–² +0.0% YoY
Operating Income (TTM)
$93,940β–² +53.5% YoY
Free Cash Flow (TTM)
$129,054β–² +53.5% YoY

About MANGOCEUTICALS INC

Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
44/100

Analyst Price Target

β“˜
Average Target
$0.73
β–² +33.3% Upside
High Target$0.87
Low Target$0.55
Based on 39 analysts

Latest News & Updates

ChartMillΒ·5d ago

On Thursday, there are stocks with unusual volume. Let's take a look.

The trading volume of these stocks is deviating from the norm in today's session.

ChartMillΒ·5d ago

Let's uncover which stocks are experiencing notable gaps during today's session.

Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.

ChartMillΒ·6d ago

Which stocks are moving before the opening bell on Thursday?

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

πŸš€
BenzingaΒ·6d ago

Mangoceuticals’ Merger Partner Nuclea Energy Signs MoU With New Mining To Study Behind-The-Meter Use Of Modular Reactors To Power High-Density Computing

MoU with New Mining Co. ("New Mining"), a Miami-headquartered provider of high-density digital infrastructure and computing hosting services, to evaluate the technical and structural feasibility of deploying

BenzingaΒ·6d ago

Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket

SiTime Corp (SITM) stock rose 30.7% in pre-market trading after beating earnings and sales estimates. Other gainers include CLRO, WYHG, SURG, PAVS, MGRX, CELZ, SOUN, WPP, HNST. YXT was the only loser after CFO resignation.

BenzingaΒ·6d ago

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

Mangoceuticals Shares surged 49.24% after hours as Nuclea Energy advanced nuclear reactor plans boosted merger-related optimism.